This association is further supported by the concurrent enrichment of higher MDSC scores (S5B Fig) and CAF scores (S5C Fig) in these patients, collectively implying that HuR may impact ICI effectiveness across diverse cancer types. This evidence concerns the gene ELAVL1 and cancer.